Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

DNA X, Inc.

CIK 1178697 SONM·Manufacturing · All EDGAR filings ↗

Progression

  1. Late filing NT 10-K
  2. Auditor change 8-K +29d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing high Filing comparison

DNA X, Inc. filed its quarterly report late and said it expects a significant change in results

expects significant change in results Filed on the statutory due date.

(the “Company”) is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the three months ended June 30, 2026 (the “Form 10-Q”) within the prescribed time period. This delay resulted primarily from accounting for the sale of convertible debt during the period and from the complexities associated with accounting for variable interest entities under Accounting Standards Codification (“ASC”) Topic 810, Consolidation. As reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2026 (the “Termination Date”), the Company entered into an Amendment No. 1 to Membership Interest Purchase Agreement with…
Evidence
Anticipates significant change
Yes
Days past due date
0
Routine
No
Severity
high
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the three months ended June 30, 2026 (the “Form 10-Q”) within the prescribed time period. This delay resulted primarily from accounting for the sale of convertible debt during the period and from the complexities associated with accounting for variable interest entities under Accounting Standards Codification (“ASC”) Topic 810, Consolidation. As reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2026 (the “Termination Date”), the Company entered into an Amendment No. 1 to Membership Interest Purchase Agreement with…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing elevated Filing comparison

DNA X, Inc. filed its quarterly report late and said it expects a significant change in results

expects significant change in results Filed on the statutory due date.

(the “Company”) is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the three months ended March 31, 2026 (the “Form 10-Q”) within the prescribed time period. This delay resulted primarily from the disposition of the Company’s legacy mobile phone and hotspot business (the “Legacy Business”), the closing of which occurred during the first quarter of 2026. In accordance with Accounting Standards Codification 205-20, Discontinued Operations, the Company is required to present the results of the Legacy Business as a discontinued operation in its condensed consolidated financial statements for the three months ended March 31, 2026. The accounting…
Evidence
Anticipates significant change
Yes
Days past due date
0
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the three months ended March 31, 2026 (the “Form 10-Q”) within the prescribed time period. This delay resulted primarily from the disposition of the Company’s legacy mobile phone and hotspot business (the “Legacy Business”), the closing of which occurred during the first quarter of 2026. In accordance with Accounting Standards Codification 205-20, Discontinued Operations, the Company is required to present the results of the Legacy Business as a discontinued operation in its condensed consolidated financial statements for the three months ended March 31, 2026. The accounting…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Auditor change high SEC item code

DNA X, Inc. moved from Baker Tilly to TAAD LLP

The company dismissed the auditor. Baker Tilly → TAAD LLP to a smaller firm

Evidence
Direction
dismissed
Direction label
The company dismissed the auditor
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Predecessor auditor
Baker Tilly
Predecessor tier
national
Severity
high
Source
SEC 8-K item code
Successor auditor
TAAD LLP
Successor tier
other
Tier downgrade
Yes
Why
The company's independent registered accounting firm changed.

Source filing ↗

Late filing elevated Filing comparison

DNA X, Inc. told the SEC it could not file its annual report on time

Does not expect a significant change in results. 1 day past the statutory due date.

The Registrant is unable to file, without unreasonable effort or expense, its Annual Report on Form 10-K for the period ended December 31, 2025 (the “Form 10-K”) within the prescribed time period. This delay resulted primarily from the acquisition of the DNA X trading platform, the closing of which occurred during the fourth quarter of 2025. The Registrant is compiling the required information to complete the Annual Report and the audit of the financial statements to be included in the Annual Report.
Evidence
Anticipates significant change
No
Days past due date
1
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
The Registrant is unable to file, without unreasonable effort or expense, its Annual Report on Form 10-K for the period ended December 31, 2025 (the “Form 10-K”) within the prescribed time period. This delay resulted primarily from the acquisition of the DNA X trading platform, the closing of which occurred during the fourth quarter of 2025. The Registrant is compiling the required information to complete the Annual Report and the audit of the financial statements to be included in the Annual Report.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗